![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Mylan Plans to Sell Generic EpiPen at Half Price
Mylan Plans to Sell Generic EpiPen at Half Price
![](https://www.fdanews.com/ext/resources/test/Drug-Images/Mylan_Logo.gif?t=1433878515&width=430)
In response to criticism surrounding the price of its EpiPen, Mylan plans to sell a generic version of its allergy treatment for half the price.
After four U.S. senators criticized the price hikes of Mylan’s EpiPen, the company announced plans to market a two-pack of generic auto-injectors for a list price of $300.
The list price of the company’s EpiPen injectors ballooned to $608 since 2008, when the product cost $100. The senators have questioned the company’s rationale for the price increase.
Upcoming Events
-
21Oct